Tracking fusion of human mesenchymal stem cells after transplantation to the heart

Stem Cells Translational Medicine

Volumn 4, Issue 6, 2015, Pages 685-694

  Freeman, Brian T ^a,c   Kouris, Nicholas A ^a   Ogle, Brenda M ^b,c,d  

^a Department of Biomedical Engineering ^*  (United States)

^b Laboratory for Optical and Computational Instrumentation   (United States)

^c University of Minnesota   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cardiac patch; Cell fusion; Cell transplantation; Cre LoxP; Mesenchymal stem cells

Indexed keywords

CRE RECOMBINASE; HLA A ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL CULTURE; CELL FUSION; CENTROMERE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSFER; HEART INFARCTION; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOXP SITE; LUCIFERASE ASSAY; MALE; MESENCHYMAL STEM CELL; MOUSE; PLURIPOTENT STEM CELL; POLARIMETRY; TRANSGENIC MOUSE; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; CELL MOTION; CELL TRACKING; CYTOLOGY; HEART; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; TRANSPLANTATION; XENOGRAFT;

MURINAE; MUS;

ANIMALS; CELL FUSION; CELL MOVEMENT; CELL TRACKING; HEART; HETEROGRAFTS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; ORGAN SPECIFICITY; PLURIPOTENT STEM CELLS;

EID: 84930518096     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0198     Document Type: Article

References (53)

1. Go AS, Mozaffarian D, Roger VL et al. Executive summary: Heart disease and stroke statistics—2013 Update: A report from the American Heart Association. Circulation 2013; 127:143–152.
2. Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007;167:989–997.
3. Amado LC, Saliaris AP, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005;102:11474–11479.
4. Chen S, Liu Z, Tian N et al. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomy-opathy due toisolated chronic occluded left anterior descending artery. J Invasive Cardiol 2006;18:552–556.
5. Chen SL, Fang WW, Ye F etal. Effect on left ventricular function of intracoronary transplan-tationofautologousbonemarrowmesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92–95.
6. Ma J, Ge J, Zhang S et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005;100:217–223.
7. Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantationinaswine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002;73:1919–1926.
8. Tomita S, Li RK, Weisel RD et al. Autolo-gous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100(suppl):II247–II256.
9. Mouiseddine M, François S, Semont A et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007;80:S49–S55.
10. Nagaya N, Fujii T, Iwase T et al. Intravenous administrationofmesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. AmJPhysiol Heart Circ Physiol 2004;287:H2670–H2676.
11. Deb A, Wang S, Skelding KA et al. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107:1247–1249.
12. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005;115:572–583.
13. Kawada H, Fujita J, Kinjo K et al. Nonhe-matopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyo-cytes after myocardial infarction. Blood 2004; 104:3581–3587.
14. Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from hu-manbonemarrowregeneratemyocardiumafter myocardial infarction. J Clin Invest 2005;115: 326–338.
15. Chen G, Nayan M, Duong M et al. Marrow stromal cells for cell-based therapy: The role of antiinflammatory cytokines in cellular cardio-myoplasty. Ann Thorac Surg 2010;90:190–197.
16. Caplan AI. Whyare MSCs therapeutic?New data: New insight. J Pathol 2009;217:318–324.
17. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98:1076–1084.
18. Gnecchi M, He H, Liang OD et al. Para-crine action accounts for marked protection of ischemic heart by Akt-modified mesenchy-mal stem cells. Nat Med 2005;11:367–368.
19. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661–669.
20. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046–1052.
21. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arte-riogenesis through paracrine mechanisms. Circ Res 2004;94:678–685.
22. Linke A, Müller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clono-genic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005;102:8966–8971.
23. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentia-tion. Nat Med 2004;10:494–501.
24. Kouris NA, Schaefer JA, Hatta M et al. Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming. Stem Cells Int 2012;2012:414038.
25. Lin HP, Vincenz C, Eliceiri KW et al. Bimo-lecular fluorescence complementation analysis of eukaryotic fusion products. Biol Cell 2010; 102:525–537.
26. Matsuura K, Wada H, Nagai T et al. Cardi-omyocytes fuse with surrounding noncardio-myocytes and reenter the cell cycle. J Cell Biol 2004;167:351–363.
27. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313–12318.
28. Sprangers AJ, Freeman BT, Kouris NA et al. A Cre-Lox P recombination approach for the detection of cell fusion in vivo. J Vis Exp 2012;51:e3581.
29. Zhang S, Wang D, Estrov Z et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes invivo. Circulation 2004;110:3803–3807.
30. Quintana-Bustamante O, Alvarez-Bar-rientos A, Kofman AV et al. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 2006;43:108–116.
31. Quintana-Bustamante O, Grueso E, Gar-cia-Escudero R et al. Cell fusion reprogramming leads to a specific hepatic expression pattern duringmousebone marrowderived hepatocyte formation in vivo. PLoS ONE 2012;7:e33945.
32. Alvarez-Dolado M, Pardal R, Garcia-Ver-dugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968–973.
33. Jeetendra E, Robison CS, Albritton LM et al. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 2002;76:12300–12311.
34. Sun X, Belouzard S, Whittaker GR. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J Biol Chem 2008;283: 6418–6427.
35. Schwenk F, Baron U, Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 1995; 23:5080–5081.
36. Trivedi P, Hematti P. Derivation and im-munological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 2008;36:350–359.
37. Takada A, Robison C, Goto H et al. A system for functional analysis of Ebola virus glyco-protein. Proc Natl Acad Sci USA 1997;94: 14764–14769.
38. Sprangers AJ, Freeman BT, Ogle BM. Elec-troporation can efficiently transfect hESC-derived mesenchymal stem cells without inducing differentiation. Open Stem Cell J 2011;3:62–66.
39. Kouris NA, Squirrell JM, Jung JP et al. A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart. Regen Med 2011;6:569–582.
40. Michael LH, Entman ML, Hartley CJ et al. Myocardial ischemia and reperfusion: A murine model. Am J Physiol 1995;269: H2147–H2154.
41. Ogle BM, Butters KA, Plummer TB et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo. FASEB J 2004;18:548–550.
42. Preda MB, Rønningen T, Burlacu A et al. Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury. Stem Cells 2014;32:2123–2134.
43. Kidd S, Spaeth E, Dembinski JL et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009;27:2614–2623.
44. Sutton EJ, Henning TD, Boddington S et al. In vivo magnetic resonance imaging and optical imaging comparisonof viable and nonvi-ablemesenchymalstemcellswithabifunctional label. Mol Imaging 2010;9:278–290.
45. Jang KS, Lee KS, Yang SH et al. In vivo tracking of transplanted bone marrow-derived mesenchymal stem cells in a murine model of stroke by bioluminescence imaging. J Korean Neurosurg Soc 2010;48:391–398.
46. Kraitchman DL, Heldman AW, Atalar E et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290–2293.
47. Kraitchman DL, Tatsumi M, Gilson WD et al. Dynamic imaging of allogeneic mesenchy-mal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451–1461.
48. Jasmin R, Jelicks LA, Koba W et al. Mesen-chymal bone marrow cell therapy in a mouse model of Chagas disease. Where do the cells go? PLoS Negl Trop Dis 2012;6:e1971.
49. Gholamrezanezhad A, Mirpour S, Bagheri M et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 2011;38:961–967.
50. Takeda Y, Tachibana I, Miyado K et al. Tet-raspaninsCD9and CD81functiontoprevent the fusion of mononuclear phagocytes. J Cell Biol 2003;161:945–956.
51. Evans MS, Chaurette JP, Adams ST Jr et al. A synthetic luciferin improves biolumi-nescence imaging in live mice. Nat Methods 2014;11:393–395.
52. Spees JL, Olson SD, Ylostalo J et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003;100: 2397–2402.
53. Terada N, Hamazaki T, Oka M et al. Bone marrowcells adoptthe phenotypeofother cells by spontaneous cell fusion. Nature 2002;416: 542–545.